Crone Michael A, Freemont Paul S
London Biofoundry, Imperial College Translation and Innovation Hub, London, United Kingdom; Imperial College London, London, United Kingdom.
Section of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, London, United Kingdom; and Imperial College London, London, United Kingdom.
GEN Biotechnol. 2022 Dec 1;1(6):496-503. doi: 10.1089/genbio.2022.0033. Epub 2022 Dec 21.
Suitable controls are integral for the validation and continued quality assurance of diagnostic workflows. Plasmids, DNA, or transcribed RNA are often used to validate novel diagnostic workflows, however, they are poorly representative of clinical samples. RNA phage virus-like particles (VLPs) packaged with exogenous RNA have been used in clinical diagnostics as workflow controls, serving as surrogates for infectious viral particles. Comparable controls for DNA viruses are more challenging to produce, with analogous DNA phages being infectious and packaging of DNA within RNA phages requiring complex purification procedures and expensive chemical linkers. We present a simple and inexpensive method to produce (MS2) VLPs, packaged with DNA, that makes use of affinity chromatography for purification and enzymatic production of exogenous DNA suitable for packaging. The produced VLPs were packaged with hepatitis B virus DNA and were then quantified using droplet digital PCR and calibrated against the WHO international standard using a commercial assay in an accredited clinical laboratory.
合适的对照对于诊断工作流程的验证和持续质量保证至关重要。质粒、DNA或转录的RNA常被用于验证新型诊断工作流程,然而,它们很难代表临床样本。包装有外源RNA的RNA噬菌体病毒样颗粒(VLP)已被用作临床诊断中的工作流程对照,作为感染性病毒颗粒的替代物。生产DNA病毒的可比对照更具挑战性,类似的DNA噬菌体具有感染性,并且在RNA噬菌体中包装DNA需要复杂的纯化程序和昂贵的化学连接物。我们提出了一种简单且廉价的方法来生产包装有DNA的(MS2)VLP,该方法利用亲和色谱法进行纯化,并通过酶促生产适合包装的外源DNA。所生产的VLP用乙型肝炎病毒DNA进行包装,然后使用液滴数字PCR进行定量,并在认可的临床实验室中使用商业检测方法根据世界卫生组织国际标准进行校准。